News

APPG AGM

13 Jul

The All-Party Parliamentary Group for Pharmacy will be holding its AGM on Wednesday, 19th July at 3:30pm. The meeting will take place in Committee Room 7 in the Palace of Westminster.

General Election

03 May

Due to the General Election, from 3 May 2017 to 8 June 2017 the House of Commons is dissolved.

The Group will therefore be making no further statements or carrying out any new activity until the after the new Parliament is elected, and the Group reconstituted.

Pharmacy and Government must work together to develop new patient services.

26 Apr

The All-Party Pharmacy Group calls on pharmacy and Government to work together to implement the recommendations of the Murray Review, and develop new and advanced patient services.

Launching the report of its investigation into the Government’s reforms of community pharmacy, the officers of the Group said that community pharmacy remains a highly valued, but underutilised resource and that its services should be developed to allow the profession to play a more integrated role in both primary care services, and the treatment of patients who suffer from long-term health conditions.

Drawing on evidence received from practicing pharmacists, local commissioners, representatives of NHS England, and the national pharmacy organisations, the Group has made seven recommendations:

  1. A minor ailments service should be available throughout England on a consistent basis.
  2. Policy makers should better understand how community pharmacies are currently used.
  3. Integration with primary care in general and community pharmacy in particular should be an objective of the GP practice pharmacist programme.
  4. All community pharmacists should have the opportunity to become prescribers.
  5. Steps should be taken to encourage the use of shared patient records between primary and secondary care.
  6. NHS England should outline their strategy for implementing the recommendations of the Murray Review into Community Pharmacy Clinical Services.
  7. Sustainability and Transformation Plans should engage more closely with community pharmacy.

The Rt Hon Sir Kevin Barron MP, Chair of the All-Party Pharmacy Group, said:

“Throughout our investigation the Group heard from numerous witnesses who argued that community pharmacy has the expertise available to play a greater role in relieving pressure on primary care, as well as treating patients who require regular assistance in the management of chronic health conditions.

Our recommendations encourage closer integration and identify a number of services which should be developed through the national pharmacy contract. We hope these recommendations will be given due consideration by the Department of Health and hope the Group will have the opportunity to discuss them with the Minister in the new Parliament.”

Oliver Colvile MP, Vice Chair of the All-Party Pharmacy Group, said:

“Community Pharmacists have the expertise and accessibility to play a much greater role in treating patients with both minor ailments and chronic conditions. The health service is facing huge challenges due to patient demand, and by working to develop services, community pharmacy can shoulder some of the burden facing GPs, and other parts of the NHS.”

The report provides the summaries of the six evidence sessions held as part of the investigation.

The officers expect the Group to be reconstituted in June, following the General Election. They hope that the Group will meet with the relevant Minister to discuss these recommendations once Parliament has reconvened.

Group postpones evidence session with Minister for Community Health and Care

21 Apr

The All-Party Pharmacy Group was scheduled to meet with David Mowat MP, Minister for Community Health and Care, as part of its final evidence session into the Government’s reforms of community pharmacy.

However, due to the calling of the General Election, this session has now been postponed. Instead, the Group will publish its final recommendations, based on the evidence recieved over its previous six meetings.

Group published report on fifth and sixth evidence sessions

21 Apr

The All-Party Pharmacy Group has published the report of its Fifth and Six evidence sessions into the Government’s reforms of community pharmacy.

These evidence sessions focused on the Murray Review into Community Pharmacy Clinical Services and also heard from the national pharmacy organisations.

You can read the report of this evidence session via the links below.

Evidence Session 5: Review of Community Pharmacy Clinical Services

Evidence Session 6: National Pharmacy Organisations

All-Party Pharmacy Group publishes third and fourth report on Government Reforms

31 Mar

The All-Party Pharmacy Group has today published the report of its Third and Fourth evidence sessions into the Government’s reforms of community pharmacy.

These evidence sessions focused on the Pharmacy Access Scheme and developments in digital pharmacy. The Group heard from witnesses drawn from NHS England, community pharmacy, Healthwatch, as well as a frequent user of community pharmacy.

You can read the report of this evidence session here

Evidence Session on Murray Review and pharmacy organisations

24 Mar

The All-Party Pharmacy Group will be meeting on Monday, 27th March at 4pm in Room A, 1 Parliament Street for a joint evidence session focussing on two key issues: the Murray Review of Community Pharmacy Clinical Services commissioned by NHS England, and also the views of leaders of the national pharmacy organisations. We are interested in understanding how the recommendations in the Murray Review are to be met in light of the Government’s reforms, as well as how the national pharmacy organisations are working to develop new services, and respond to current challenges, including the recent funding changes.

Witnesses at the session will include:
At 4pm

  • Richard Murray (Leader of the Review of Community Pharmacy Clinical Services and Director of Policy, The King’s Fund)

Followed at 4.45pm by

  • Sue Sharpe (Chief Executive, Pharmaceutical Services Negotiating Committee)
  • Sandra Gidley (Chair, English Pharmacy Board, Royal Pharmaceutical Society)
  • Ian Strachan (Chair, National Pharmacy Association)
  • Nanette Kerr (Chief Executive, Company Chemists Association)

All-Party Pharmacy Group announces forthcoming evidence sessions

09 Mar

The Group has now confirmed the dates of the remaining evidence sessions which have been scheduled as part of its investigation into the Government’s reforms of community pharmacy. The topics of these upcoming evidence sessions, along with their meeting details are;

  • The Murray Review and Pharmacy Organizations – Room A, 1 Parliament Street – 27th March at 4pm.
  • David Mowat MP, Minister for Community Health and Care – CR 18 – 25th April at 3pm.

All-Party Pharmacy Group publishes second report on Government reforms

08 Mar

The All-Party Pharmacy Group has today published the report of its second evidence session into the Government’s reforms of community pharmacy. This evidence session focused on the Minor Ailments Service. The Group heard from expert witnesses drawn from both community pharmacy and clinical commissioning groups experienced in commissioning and implementing minor ailments, and other locally commissioned services across the country.

You can read the report of this evidence session here

Evidence Session on Pharmacy Access and Digital

08 Mar

The All-Party Pharmacy Group will be meeting on Monday, 13th March at 3pm in Room A, 1 Parliament Street for a joint evidence session on the Pharmacy Access Scheme and ‘digital pharmacy’.

This meeting is part of the Group’s investigation into the Government’s reforms of community pharmacy and will focus on two aspects of those reforms: access to community pharmacies and the development of digital pharmacy. We are interested in understanding how patients’ access to local pharmacies is likely to change as a result of the Government’s reforms, particularly in rural and deprived urban areas, as well as how developments in electronic patient records, electronic prescriptions and online services are changing the traditional patient/ pharmacist dynamic.

The running order for Monday is as follows:

3pm-Pharmacy Access. Witnesses for this session include;

  • Olivier Picard (Director, Newsdays Pharmacy Ltd)
  • Mark Burdon (Burdon Pharmacy Group)
  • Imelda Redmond (National Director, Healthwatch)
  • Hector Morini (patient)

3:45pm-Digitial Pharmacy. Witnesses include;

  • Mark Burdon (Burdon Pharmacy Group)
  • Imelda Redmond (National Director, Healthwatch)
  • Richard Ashcroft (Programmes Manager, NHS Digital)

Evidence session on Minor Ailments

13 Feb

The All-Party Pharmacy Group session investigating the Minor Ailments Service and other locally commissioned services will now take place on 27th February at 3pm in Room A, 1 Parliament Street. The witnesses for the evidence session will include:

  • Ruth Buchan (Chief Executive Officer, Community Pharmacy West Yorkshire)
  • Paula Johnson-Laired (Medicines Optimisation Team, Leeds West CCG)
  • Helen Murphy (Chief Executive Officer, Community Pharmacy Cheshire and Wirral)
  • Jane Devenish (NHS Standards Pharmacist, Well Pharmacy

Group reschedules evidence session

03 Feb

The meeting of the All-Party Pharmacy Group scheduled to take place on 6th February at 4pm, has been postponed due to the upcoming London Underground strike and unavoidable Parliamentary business. The evidence session looking at the Minor Ailments Service and other locally commissioned services will take place at a date to be announced on this website

All-Party Pharmacy Group publishes first report on Government reforms

01 Feb

The All-Party Pharmacy Group has today published the report of its first evidence session into the Government’s reforms of community pharmacy. The evidence session (the first of seven) focused on the role of pharmacists working in GP surgeries. The Group heard from expert witnesses drawn from both community pharmacy and clinical commissioning groups experienced in the roll-out of the clinical pharmacist pilots.

Drawing on the evidence heard, the Group has made a number of recommendations. These include;
1. Steps should be taken to encourage the use of shared patient records to accommodate greater joint working within and between primary and secondary care
a. All pharmacists, whether they are based in GP surgeries or in community pharmacies, would be able to better provide services to patients if they had access to the same records that GPs use. That the Government announced in 2015 that pharmacists would have access to Summary Care Records shows that it already recognises the benefits that access to patient records would bring.
b. Providing pharmacists with full read and write access to patient records is a logical next step. This would improve patient care by enabling pharmacists to play an even greater role in the provision of care and also allow other healthcare professionals to be aware of interventions made by pharmacists. The All Party Pharmacy Group previously called for the Government to set out plans to accomplish this by April 2017. Now that the roll-out of Summary Care Records has been completed, the Government should set out its proposal on full read and write access for pharmacists in community pharmacies and in GP surgeries.
2. A full evaluation of the pilots should be conducted on their impact on patient services.
a. Full evaluations should be carried out on all of the pilot schemes. They should analyse not only patient satisfaction, or the number of interventions relating to medicines, but also the effect within the GP practice such as the number of patients treated, the hours of GP time which have been freed up as a result of pharmacist intervention and other effects on joint working and communication within the practice. Any evaluation should also take account of the potential impact of a wider roll out of the scheme.
b. Any evaluation should also take into account the impact which further integration has had on the wider primary care eco-system, particularly between GP surgeries and community pharmacies.
3. More community pharmacists should be encouraged to become prescribers.
a. The integration of clinical pharmacists in GP practices has been successful, partly due to the integration of the capability to prescribe and dispense medicines in a single location.
b. More community pharmacists should be encouraged to qualify for independent prescriber status. This would allow for the diagnosing of conditions and prescribing medicines to patients, allowing community pharmacy to play a more active and expanded role.
4. Encourage GPs to use pharmacist premises.
a. The Government should investigate the feasibility of providing GP services in community pharmacy premises, particular those belonging to large multiples, in order to take advantage of shared facilities.

The Rt Hon Sir Kevin Barron MP, Chair of the All-Party Pharmacy Group, said “The Group saw that basing pharmacists in GP surgeries is an excellent way to improve prescribing and for patients to benefit from pharmacists’ expertise in medicines. That is already happening in Devon and Sheffield. These pilots are not a replacement for community pharmacies, and indeed if the scheme is to succeed they should look at closer cooperation between surgeries involved in the pilots and their local community pharmacies. Once again we are calling for the Government to prioritise pharmacists’ access to patient records. We can’t truly join up primary care until we are all literally reading from the same page.

Oliver Colvile MP, Vice of Chair of the All-Party Pharmacy Group, also said “It was heartening to hear from expert witnesses involved in the roll-out of the clinical pharmacist pilots, and especially positive to see great strides being made in Devon. Pharmacy has much to offer and joining up primary care means having the right expertise in the right place. The success of these pilots begs the question – are there situations where GP consultations could happen in pharmacies?”

The next session of the All-Party Pharmacy Group’s investigation will be taking place on Monday, 6th February at 4pm.

You can read the full report of the first evidence session here

Group to hold second evidence session on locally commissioned services

31 Jan

On Monday, 6th February 2017 at 4pm in Room A, 1 Parliament Street, the All-Party Pharmacy Group will be holding the second evidence session of its investigation into the Government’s reforms for community pharmacy.

The session will focus on the Minor Ailments Service and other locally commissioned services and will be attended by representatives of pharmacy and local commissioning groups, allowing them to share their views on how such services can play an expanded role in supporting primary care.

The witnesses will include;

  • Mark Burdon (community pharmacist and pharmacy owner)
  • Ruth Buchan (Chief Executive Officer, Community Pharmacy West Yorkshire)
  • Paula Johnson-Laired (Medicines Optimisation Team, Leeds West CCG)
  • Helen Murphy (Chief Executive Officer, Community Pharmacy Cheshire and Wirral

If you would be interested in attending please RSVP to the Group’s secretariat on appg-team@luther.co.uk or call Tom Woolhouse on 0207 618 9100

Group responds to Government statement on decrimininalisation of perscription errors

17 Jan

The All Party Pharmacy Group welcomes news of progress on long-awaited reforms to decriminalise dispensing errors by pharmacists. According to David Mowat, Minister for Community Health and Care, who was responding to a Parliamentary Question by APPG Vice Chairman Oliver Colvile MP, the Department for Health will ‘shortly’ make the necessary changes to the law, having consulted on proposals to put in place a defence to the criminal sanction for inadvertent dispensing errors.

Oliver Colvile MP said of the news, “The All Party Pharmacy Group has campaigned long and hard on this issue. It is a ridiculous anomaly that pharmacists can go to prison for an honest mistake and I am delighted that the minister has listened to our concerns and we finally have progress on reforming the law. Making new legislation can be a long and frustrating process, but today we took one more step closer to levelling the playing field and righting this long-standing injustice. ”

Group to hold evidence session on pharmacists in GP surgeries

10 Jan

On Tuesday, 17th January 2017 at 3pm in Committee Room 17 of the House of Commons, the All-Party Pharmacy Group will be holding the first evidence session of its inquiry into the Government’s reforms for community pharmacy.

The session will focus on the role of pharmacists in GP surgeries and will be attended by representatives of pharmacy and NHS England, allowing them to share their views and answer questions on the rollout of the Government’s pilot to increase the number of clinical pharmacists working in GP practices.

The witnesses will include;

  • Dr Peter Magirr, Quality and Strategy Lead for Medicines Management at NHS Sheffield Clinical Commissioning Group.
  • Crispin Bliss, Vice Chair of Sheffield LPC.
  • David Bearman, Chair of Devon LPC.

If you would be interested in attending please RSVP to the Group’s secretariat on appg-team@luther.co.uk or call Tom Woolhouse on 0207 618 9100

Lords Debate: Enhancing the role of community pharmacies in providing NHS services to patients and the public

08 Dec

On Tuesday, 6th December the House of Lords debated how to enhance the role of community pharmacies in providing NHS services to patients and the public. The debate was tabled by Baroness Cumberlege, Vice Chair of the All-Party Pharmacy Group.

Below is a summary of the key contributions made during the debate.

Baroness Cumberlege (Con) opened the debate by highlighting the PwC report into the economic value of community pharmacy. She quoted the £3billion figure which community pharmacy contributes to the NHS, public-sector and patients through services which exclude the dispensing of medicines, and asked the Government to reverse the 7.4% cut and instead invest in further services to help relieve pressure on the NHS.

Lord Prior of Brampton (Con) (Parliamentary Under Secretary of State at the Department for Health) clarified that the 7.4% cut will be spread over two years and not one year as implied by Baroness Cumberlege, and said that he does foresee an increase in the services offered by community pharmacy over the next ten years.

Baroness Pitkeathley (Lab) highlighted that community pharmacy plays an important role in rural areas that goes beyond the dispensing of medicines and asked that this valuable role be safeguarded.

Lord Prior responded that the Pharmacy Access Scheme will ensure that pharmacies in rural or deprived areas will be supported through a greater level of funding.

Lord Low of Dalston (CB) also asked that the cuts be reversed and community pharmacy invested in to help relieve pressure on the NHS.

Lord Prior replied by saying that the NHS needs to make efficiency savings and pharmacy cannot be exempt. However, as before, he did say that he foresees pharmacy playing a greater role over the next few years.

Lord Hunt of Kings Heath (Lab) criticised the Government for reducing patient choice given the role which pharmacy can play in reducing demand on GPs.

Lord Prior responded that due to the clustering of pharmacies, paying an establishment feed is no longer a useful allocation of resources.

Baroness Janke (Lib-Dem) asked the Government to publish the cost based evidence justifying the cuts to community pharmacy. She also asked that safeguards be put in place to ensure that the most needy communities are not hit hardest by the cuts.

Lord Prior referred again to the Pharmacy Access Scheme and said how it would prevent this from occurring. Regarding the report, he said he would have to investigate before responding to her.

Baroness Gardner of Parkes (Con) emphasised the role of pharmacies in providing a free alternative to dentists in helping to diagnose and treat oral conditions.

Lord Prior praised the level of service offered by pharmacies and the role which they have to play in society.

Baroness Finlay of Llandaff (CB) asked the Government to review the funding model for community pharmacy to take into account the increase in diagnostic and advice services being offered by pharmacists, despite the cuts in funding they will now experience.

Lord Prior said the new funding model moves away from a volume based payment structure through the removal of the establishment fee. Instead, the Pharmacy Integration Fund will allow pharmacies to provide some of the care currently provided by GPs.

APPG Investigation into the Government's reforms of community pharmacy-schedule of meetings

17 Nov

APPG Investigation into the Government’s reforms of community pharmacy

Schedule of meetings

Officers of the All-Party Pharmacy Group have agreed to hold six evidence sessions in the Group’s investigation into the community pharmacy reforms announced by the Department of Health on 20 October 2016.

These evidence sessions will each address a specific aspect of the package of reforms, as per the schedule below. The Group will confirm witnesses for each session as soon as possible. The meetings will be open to observers, subject to capacity. Anyone wishing to observe a particular session should contact the secretariat appg-team@luther.co.uk once dates are confirmed.

Session 1 : Pharmacists in GP surgeries

Session 2: Minor Ailments Service

Session 3: The Murray Review and the development of services in community pharmacies

Session 4: Access to community pharmacies

Session 5: Digital pharmacy, including click & collect, electronic integration and online pharmacy, Summary Care Records.

Session 6: David Mowat MP and officials from the Department of Health and NHS England

The Group may decide to hold more sessions as part of this investigation. If so, information will be posted on our website.

The Group welcomes written submissions on the topics under investigation. They should be no more than 2,500 words and in Word format. Submissions should be sent to the Secretariat.

APPG Inquiry Terms of Reference

08 Nov

The All-Party Pharmacy Group has today announced terms of reference for its inquiry into the Government’s reforms of community pharmacy funding.

The Group will investigate the proposed funding cuts and the impact on community pharmacy services and staffing levels. The Group will also seek to understand the role of the Integration Fund in fostering a modern community pharmacy service, and how the Minor Ailments Service will be rolled out across England.

The All-Party Pharmacy Group will begin its investigation in November 2016 and hold a number of evidence sessions inviting, among others, Department of Health officials, NHS England, representatives of the pharmacy sector and service users to give evidence. Following each session, the Group will publish a statement of the evidence received, along with any recommendations.

The Rt Hon, Sir Kevin Barron MP, Chair of the All-Party Pharmacy Group, said of the investigation, “The All-Party Pharmacy Group has previously called for further investment in community pharmacies to allow them to provide more health services and ease the burden on GP surgeries and hospitals. The Department of Health believes this can be achieved with the new funding package that has been announced. The Group will therefore scrutinise what is being proposed in detail to better understand what their reforms will mean for community pharmacies, and the patients they serve.”

You can read the terms of reference for the inquiry here.

Note of meeting with David Mowat and Officials

04 Nov

The All Party Pharmacy Group has published a summary note of its meeting with David Mowat MP, Minister for Community Health and Care, which took place on 24th October 2016 to discuss the Government’s newly announced reforms of funding for community pharmacy.

You can read the report by clicking here.

MPs to meet with MHRA Chief Executive on the EU’s Falsified Medicines Directive

24 MAY

The Rt Hon Kevin Barron MP will meet on June 5th with Professor Sir Kent Woods, Chief Executive of the MHRA, to discuss the Government’s plans for implementing the EU’s Falsified Medicines Directive. The private meeting follows a public meeting of the All-Party Pharmacy Group, earlier this month, which discussed the Government’s plans for implementation.

Commenting ahead of the meeting, Rt Hon Kevin Barron, Chair of the All-Party Pharmacy Group, said:

“I’m pleased that Sir Kent has decided to take the time to update me on his organisation’s plans for implementing the EU’s Falsified Medicines Directive. Keeping counterfeit medicines out of the medicines supply chain is vital for patient safety, and effective implementation of this directive will be crucial. This is an issue which the Group will continue to explore, and there will be new meetings on the issue in the near future.”

Click here to view the press release

MPs call on Government to do more to tackle the problem of medicines shortages

23 MAY

A year on from the its inquiry into the problem of medicines shortages, Members of the All-Party Pharmacy Group have called on the Government to do more to alleviate the problem.


Commenting, the Rt Hon Kevin Barron MP, Chairman of the All-Party Pharmacy Group said:

“It’s now been a year since the All-Party Pharmacy Group held a major inquiry into the problem of medicines shortages. Our report made a number of recommendations to Government about what needed to be done to end the problem. But a year a year on, much remains the same. I’ve continued to receive evidence on the impact of medicines shortages and I’m absolutely clear; medicines shortages is causing patient harm, and patients with very serious conditions are suffering extreme distress as result of not being able to get the medicines they need.

The Government needs to accept that this is a real problem, it’s affecting thousands of people, and it urgently needs to end. We laid out clear recommendations in our report for how this problem might be solved – and we wouldn’t be in this situation if the Government had followed them. I encourage the Government to look again at what we recommended and to act in the best interest of patients. In particular, the Government needs to look again at the possibility of exempting medicines from export on public health grounds, and to explore the possibility of imposing sanctions on those who unjustifiably violate the Government’s own supply chain guidance.”

Click here to view the press release

APPG meeting on the EU’s Falsified Medicines Directive

13 MAY

The APPG held a successful public meeting on the EU’s Falsified Medicines Directive.

Kevin Barron, Chair of the Parliamentary All Party Pharmacy Group, has provided the following comment on the meeting:

“This week’s public meeting on the EU’s Falsified Medicines Directive was a useful one. It’s encouraging that the EU has taken such a bold lead in addressing the issue of counterfeit medicines, but we will only benefit from the Directive if it is implemented effectively in the UK. 

The 2017 implementation date may seem a long way off, but what was very clear from this week’s meeting was that we only have a short window of time in which to get implementation right – this deadline is not one we can afford to allow the Government to sleepwalk toward. I’m disappointed that the MHRA was not able to send a representative to this week’s meeting – they’re absolutely central to this debate, and we will be inviting them to speak at a follow up meeting in the months ahead. Time is not yet running out – but it will soon start to. What’s clear is that the MHRA urgently needs to enter into a real dialogue about implementation of the Falsified Medicines Directive with both pharmacy in the UK as well as with the European Commission. The All-Party Pharmacy Group will be keeping up the pressure on this issue, and will be asking Parliamentary Questions too – we’ll be keeping a very close eye on the situation”.

Click here to view the press release

Oliver Colvile MP raises issue of decriminalising dispensing errors

15 APR

Oliver Colvile MP, Vice-Chair of the All-Party Group, raised the issue of decriminalising dispensing errors made by pharmacists in an adjournment debate on Community Pharmacies.

Oliver Colvile (Plymouth, Sutton and Devonport) (Con):

"I recognise that the hon. Gentleman is saying that pharmacists do an incredibly good job, and I agree, but does he agree that we should seek to decriminalise any dispensing errors that pharmacists might make? They can go to prison for such errors, but GPs are merely struck off."

Oliver Colvile MP calls for formal Parliamentary debate

22 MAR

Oliver Colvile MP, Vice Chair of the All Party Pharmacy Group , has called for a formal Parliamentary debate to be held on decriminalising dispensing errors made by pharmacists.

Click here to view the press release

Group held a public meeting on decriminalising dispensing errors made by pharmacists

28 JAN

The Group held a public meeting on the subject of decriminalising dispensing errors made by pharmacists
Kevin Barron, Chair of the Parliamentary All Party Pharmacy Group provided the following comments on the issue:

“the All-Party Pharmacy Group has always been clear that pharmacists should not face the prospect of prison and a criminal record for making a genuine dispensing error - professional regulation is, in our view, a far more appropriate route for addressing such errors. Not only would that provide public protection, it would also improve the learning culture within the profession and the NHS, and enhance patient safety. The Government must not use failure elsewhere in the NHS as a basis for further delaying the decriminalisation of genuine dispensing errors”.

Click here to view the press release

Group to hold public meeting on the subject of decriminalising dispensing errors made by pharmacists

10 JAN

On January 28th 2013, 2pm, House of Commons – The Group will hold a public meeting on the subject of decriminalising dispensing errors made by pharmacists.

Witnesses will include representatives from the Crown Prosecution Service, General Pharmaceutical Council, MHRA, and Department of Health.

Upcoming Event

APPG AGM

18 July 2017

The All-Party Parliamentary Group for Pharmacy will be holding its AGM on Wednesday, 19th July at 3:30pm. The meeting will take place in Committee Room 7 in the Palace of Westminster.

© 2017


AGM

19 July 2017

The All-Party Parliamentary Group for Pharmacy will be holding its AGM on Wednesday, 19th July at 3:30pm. The meeting will take place in Committee Room 7 in the Palace of Westminster.

Any Parliamentarians wishing to attend should contact the office of Sir Kevin Barron MP, who can be reached at barronk@parliament.uk.

© 2017

This is not an official website of the House of Commons or the House of Lords. It has not been approved by either House or its committees. All-Party Parliamentary Groups are informal groups of Members of both Houses with a common interest in particular issues. The views expressed in these webpages are those of the group. The All-Party Pharmacy Group receives financial support from: Pharmaceutical Services Negotiating Committee (PSNC), the Royal Pharmaceutical Society (RPS) and Pharmacy Voice (PV). Secretariat functions are provided by Luther Pendragon. A full list of Luther Pendragon’s clients can be found here